Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract outlines a funding opportunity by the Centers for Disease Control aimed at reducing tuberculosis (TB) morbidity and mortality in India, the Philippines, and Vietnam. With an anticipated fiscal year funding of approximately $3 million for Year 1, the program focuses on enhancing TB case finding, prevention, treatment, and surveillance. Key activities include expanding and improving TB diagnosis, particularly for early, asymptomatic, and drug-resistant cases, using innovative screening and diagnostic methods. The initiative also aims to improve outcomes for TB preventive treatment and treatment regimens, with an emphasis on shorter, more tolerable therapies. Strengthening surveillance to support data-driven decision-making and public health strategies is another critical component. This effort targets Asia due to its high burden of TB and multidrug-resistant TB, aligning with the America First Global Health Strategy by concentrating on countries heavily contributing to the TB burden. The program seeks to bolster timely and effective TB control measures through innovative approaches and evidence-based scaling of interventions in these priority countries. The overall purpose is to improve public health outcomes by reducing TB transmission, improving treatment success, and enhancing surveillance systems for better program planning and response.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds.
The purpose of this NOFO is to reduce TB-related morbidity and mortality in India, the Philippines, and Vietnam by strengthening:
• TB case finding, including linked activities such as screening, testing, and diagnostic evaluation.
• TB prevention, including TB preventive treatment (TPT).
• TB treatment, including linkage and improved treatment regimens, as appropriate.
• Surveillance, through adopting, evaluating, and expanding innovative approaches.
Activities implemented will focus on:
• Expanding and improving diagnosis of TB infection and TB disease, including early and asymptomatic TB as well as drug-resistant or multidrug-resistant TB. This will be done by using and evaluating innovative screening and diagnostic methods and scaling up evidence-based approaches.
• Improving TPT outcomes for all individuals at high risk of developing TB disease and improving TB treatment outcomes of individuals with TB disease, including those with drug-resistant or multidrug-resistant TB. This will be done by using new, shorter, and better-tolerated treatment regimens.
• Strengthening TB surveillance for data-driven decision making, program planning, and public health action.
Asia carries the highest burden of TB and drug-resistant or multidrug-resistant TB globally. This NOFO will focus on activities in India, the Philippines, and Vietnam because they are three of the top four countries contributing to the TB burden in the U.S. This aligns with the America First Global Health Strategy.
